CN Patent

CN119033771A — 软性抗胆碱能药类似物的制剂

Assigned to Bodor Laboratories Inc · Expires 2024-11-29 · 1y expired

What this patent protects

包含软性格隆溴铵的局部用制剂可用于治疗受试者(如患有多汗症的人)的出汗过多状况。优选地，在无水制剂中以有效量或浓度提供至少一种软性抗胆碱能剂，所述无水制剂能抑制因诸如多汗症的状况引起的汗脱。

USPTO Abstract

包含软性格隆溴铵的局部用制剂可用于治疗受试者(如患有多汗症的人)的出汗过多状况。优选地，在无水制剂中以有效量或浓度提供至少一种软性抗胆碱能剂，所述无水制剂能抑制因诸如多汗症的状况引起的汗脱。

Drugs covered by this patent

Ecclock (SOFPIRONIUM BROMIDE) · Kaken Pharmaceutical

Patent Metadata

Patent number: CN119033771A
Jurisdiction: CN
Classification: —
Expires: 2024-11-29
Drug substance claim: No
Drug product claim: No
Assignee: Bodor Laboratories Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.